Slim Colonoscope has 3.8 mm instrument channel, wide FOV.

Press Release Summary:



Featuring 3.8 mm instrument channel, Fuse® Full Spectrum Endoscopy C38s provides physicians with panoramic 330° field of view (FOV) in slim profile endoscope. Field of view optimizes adenoma detection capability for physicians and can consequently reduce healthcare costs while minimizing patient anxiety regarding missed pre-cancerous lesions.



Original Press Release:



EndoChoice Expands Fuse® Portfolio with Release of Slim Colonoscope



World's First Endoscope with Wide Angle of View, Slim Profile, and Large Working Channel Now Available



ATLANTA -- EndoChoice(®) today fulfilled customer orders for Fuse slim colonoscopes.  This innovative endoscope, called the C38s, is the latest advancement in the Fuse(®) Full Spectrum Endoscopy(®) portfolio and provides physicians with a panoramic 330 degree field of view in a slim profile endoscope - all while maintaining a large 3.8mm instrument channel.  EndoChoice is the only company in the world to provide this combination of features.



"The new C38s slim colonoscope drives and performs like a traditional colonoscope with all of the benefits of a slim diameter," said Dr. Steven Morris, CEO of Atlanta Gastroenterology Associates. "The larger channel means I don't sacrifice functionality when I use a slimmer scope. This is a real breakthrough."



A recent study published in March 2014 in The Lancet Oncology demonstrated the panoramic 330 degree field of view provided by the Fuse technology enabled physicians to detect significantly more adenomas in comparison with traditional forward-viewing colonoscopes. The ability to detect more adenomas during colonoscopy has the potential to reduce healthcare costs while also minimizing patient anxiety over concerns pre-cancerous lesions are being missed.



"At EndoChoice, our mission is to serve the GI caregiver through insight and innovation," said Mark Gilreath, Founder and CEO at EndoChoice, Full Spectrum Endoscopy.  "The C38s slim colonoscope is yet another example of how EndoChoice is partnering with physicians to advance their practices."



About EndoChoice

Based in Atlanta GA, EndoChoice is a medtech company focused on the manufacturing and commercialization of platform technologies including devices, diagnostics, infection control and endoscopic imaging for specialists treating a wide range of gastrointestinal diseases. EndoChoice leverages its direct sales organization to serve more than 2,500 customers in the United States and works with 34 distribution partners world-wide. The Company was founded in 2008 and has rapidly developed a proprietary product portfolio, which includes the revolutionary Full Spectrum Endoscopy System (Fuse).



2014 marked the fifth consecutive year EndoChoice was recognized as one of the fastest growing companies in the U.S. by Inc. Magazine. To learn more, visit www.endochoice.com.



EndoChoice, Full Spectrum Endoscopy and Fuse are registered trademarks of EndoChoice, Full Spectrum Endoscopy, Inc.



For more information, press only:

Doug Ladd

Chief Marketing Officer

513-608-6873 or Doug.Ladd@endochoice.com



For more information on Fuse

www.endochoice.com/fuse

www.fusecolonoscopy.org

All Topics